Literature DB >> 32762169

[Relationship of group B streptococcus colonization in late pregnancy with perinatal outcomes].

Lindong Yang1, Fang Bao1,2, Yuanzhe Wu1, Lizhou Sun3.   

Abstract

OBJECTIVE: To investigate the relationship of group B streptococcus (GBS) colonization in late pregnancy with perinatal outcome.
METHODS: Pregnant women who underwent antenatal check-up at General Hospital of PLA Eastern Theater Command and the First Affiliated Hospital of Nanjing Medical University from January 2016 to December 2018 were enrolled in the study. The vaginal and rectal swab samples were collected for GBS culture at 35-37 weeks of pregnancy. The perinatal outcomes of positive and negative GBS groups were compared. The GBS-positive group samples were tested for antibiotic susceptibility. In GBS positive group the maternal and child perinatal outcomes were compared between pregnant women with antibiotics treatment and those without antibiotics.
RESULTS: A total of 13 000 pregnant women were enrolled, and the overall colonization rate of GBS was 3.65%(475/13 000). The colonization rate of GBS in the vagina was 2.33%(303/13 000), and the colonization rate in the rectum was 1.75%(227/13 000). Through the collection and detection of rectal specimens, the positive rate of GBS increased by 56.77%(172/303). The monthly colonization rate of GBS showed significant fluctuations with the highest in March and October (all P < 0.05). The sensitivity of 475 GBS-positive specimens to ceftriaxone, vancomycin and linezolid were 100%, and the sensitivity to ampicillin and penicillin were 97.26%and 93.47%, respectively. The resistance rates of the strains to levofloxacin, clindamycin, erythromycin and tetracycline were 30.11%, 48.00%, 52.21%and 88.63%. The incidence of premature rupture of membranes, postpartum hemorrhage, puerperal infection, neonatal pneumonia and sepsis in GBS positive group were significantly higher than those in GBS negative group (all P < 0.01). In pregnant women with positive GBS, the incidence of puerperal infection, neonatal infection and admission to the NICU in the antibiotic group were significantly lower than those in the non-antibiotic group ( P < 0.05 or P < 0.01).
CONCLUSIONS: The total colonization rate of GBS is low. The detection of GBS can be significantly improved by supplementing rectal examination. Ceftriaxone, ampicillin and penicillin are currently the drugs of choice for the prevention and treatment of GBS-related diseases. GBS infection can increase the incidence of maternal and child complications. The use of antibiotics during labor can improve the outcome of mothers and infants.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32762169      PMCID: PMC8800799          DOI: 10.3785/j.issn.1008-9292.2020.04.12

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  24 in total

1.  The importance of neutrophils in resistance to pneumococcal pneumonia in adult and neonatal mice.

Authors:  B A Garvy; A G Harmsen
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

Review 2.  Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis.

Authors:  Karen M Edmond; Christina Kortsalioudaki; Susana Scott; Stephanie J Schrag; Anita K M Zaidi; Simon Cousens; Paul T Heath
Journal:  Lancet       Date:  2012-01-04       Impact factor: 79.321

3.  Epidemiology of group B Streptococcus ST-17 clone in pregnant women of South Taiwan.

Authors:  Yen-Ying Ma; Te-Yao Hsu; Shu-Yun Shen; Tsi-Shu Huang; Jau-Sung Moh; Cheng-Min Liu; Chia-Yu Ou; Hao Lin
Journal:  Gynecol Obstet Invest       Date:  2012-04-17       Impact factor: 2.031

4.  Evaluation of chromogenic medium and direct latex agglutination test for detection of group B streptococcus in vaginal specimens from pregnant women in Lebanon and Kuwait.

Authors:  Nahed Ghaddar; Wadha Alfouzan; Elie Anastasiadis; Tamima Al Jiser; Saad Eddine Itani; Racha Dernaika; Toufic Eid; Ali Ghaddar; Adib Charafeddine; Rita Dhar; Hiba El Hajj
Journal:  J Med Microbiol       Date:  2014-07-31       Impact factor: 2.472

5.  Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.

Authors:  Christina R Phares; Ruth Lynfield; Monica M Farley; Janet Mohle-Boetani; Lee H Harrison; Susan Petit; Allen S Craig; William Schaffner; Shelley M Zansky; Ken Gershman; Karen R Stefonek; Bernadette A Albanese; Elizabeth R Zell; Anne Schuchat; Stephanie J Schrag
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

6.  Prevalence of cefotaxime resistance in group B streptococcus isolates from Osaka, Japan.

Authors:  Yoshiro Morikawa; Miyoshi Kitazato; Chihiro Katsukawa; Aki Tamaru
Journal:  J Infect Chemother       Date:  2003-06       Impact factor: 2.211

7.  Group B Streptococcal infection in neonates and colonization in pregnant women: An epidemiological retrospective analysis.

Authors:  Ching-Yi Cho; Yi-Hsuan Tang; Yu-Hsuan Chen; Szu-Yao Wang; Yi-Hsin Yang; Ting-Hao Wang; Chang-Ching Yeh; Keh-Gong Wu; Mei-Jy Jeng
Journal:  J Microbiol Immunol Infect       Date:  2017-08-23       Impact factor: 4.399

Review 8.  An overview of global GBS epidemiology.

Authors:  Kirsty Le Doare; Paul T Heath
Journal:  Vaccine       Date:  2013-08-28       Impact factor: 3.641

Review 9.  Epidemiology of Group B Streptococcus in developing countries.

Authors:  Atul Kumar Johri; Hem Lata; Puja Yadav; Meenakshi Dua; Yonghong Yang; Xiaoning Xu; Akira Homma; Michèle Anne Barocchi; Matthew J Bottomley; Allan Saul; Keith P Klugman; Steven Black
Journal:  Vaccine       Date:  2013-08-28       Impact factor: 3.641

10.  Etiology and Clinical Features of Full-Term Neonatal Bacterial Meningitis: A Multicenter Retrospective Cohort Study.

Authors:  Min Xu; Lan Hu; Heyu Huang; Liping Wang; Jintong Tan; Yongjun Zhang; Chao Chen; Xi Zhang; Lisu Huang
Journal:  Front Pediatr       Date:  2019-02-13       Impact factor: 3.418

View more
  1 in total

1.  Antimicrobial resistance in colonizing group B Streptococcus among pregnant women from a hospital in Vietnam.

Authors:  Vu Van Du; Pham Thai Dung; Nguyen Linh Toan; Can Van Mao; Nguyen Thanh Bac; Hoang Van Tong; Ho Anh Son; Nghiem Duc Thuan; Nguyen Thanh Viet
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.